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Abstract 
BACKGROUND: Blood pressure control is disappointingly suboptimal in populations. Whether metabolic abnormalities 
influence blood pressure control is unclear. We evaluated the relationship between metabolic risk factors and blood 
pressure control in a large population of patients with hypertension. 
METHODS: From our Hypertension Centre, 4551 subjects (43.4% women; age 51 +/- 12 years) were selected with 
available data for metabolic and cardiovascular evaluation (no prevalent cardiovascular disease), at the last control visit. 
A modified Adult Treatment Panel III definition of metabolic syndrome was adopted changing waist girth for body mass 
index (>or= 30 kg/m2). Blood pressure was considered controlled when supine office blood pressure was below 140/90 
mmHg, or uncontrolled if this target was not achieved. Blood pressure control has been evaluated in relation to metabolic 
risk factors, adjusting for age, sex, and the number of antihypertensive medications. 
RESULTS: The metabolic syndrome phenotype was found in 1444 individuals (31.72%). The probability of uncontrolled 
blood pressure was 43% higher in patients with the metabolic syndrome than in those without, independently of 
covariates. This probability was also confirmed in 728 untreated patients. The probability of uncontrolled blood pressure 
significantly and independently increased with the increasing number of metabolic risk factors. Uncontrolled blood 
pressure was also independently associated with the prescription of more medications. 
CONCLUSION: Insufficient control of blood pressure is independently associated with the presence of the metabolic 
syndrome. Blood pressure control worsens with the increasing number of metabolic risk factors associated with 
hypertension, despite the use of a greater number of medications. 
 
